The Journal of pharmacology and experimental therapeutics

Keyphrases

Publications

volume 391, number 1, 2024

James A Carr, Daniel J Morgan
Methocinnamox is a Potent and Long-Acting Antagonist that can Prevent and Reverse Opioid-Induced Respiratory Depression. The Journal of pharmacology and experimental therapeutics 391 (1) (2024)
William E Fantegrossi, Brenda M Gannon
A "Furious" Effort to Develop Novel 3,4-Methylenedioxymethamphetamine-Like Therapeutics. The Journal of pharmacology and experimental therapeutics 391 (1) (2024)

volume 390, number 2, 2024

Anna P Malykhina, Luke Grundy
Special Section on Therapeutic Approaches to Treat Disorders of the Urinary and Gastrointestinal Tracts-Editorial. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Andrea Cignarella, Cristina D Peterson
Mechanistic Chronopharmacology: Preclinical Modeling of an SGLT2 Inhibitor in Preventing Painful Diabetic Neuropathy. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Alex J Roy, Jeffrey R Leipprandt, Joseph R Patterson, Anna C Stoll, Christopher J Kemp, Zaipo-Tcheisian D Oula, Tyler Mola, Ana R Batista, Caryl E Sortwell, Miguel Sena-Esteves, Richard R Neubig
AAV9-Mediated Intrastriatal Delivery of GNAO1 Reduces Hyperlocomotion in Gnao1 Heterozygous R209H Mutant Mice. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Liya Y Qiao
Satellite Glial Cells Bridge Sensory Neuron Crosstalk in Visceral Pain and Cross-Organ Sensitization. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Jason B Cook, Raymond Piatt, Edward Burgard, Karl B Thor, Lesley Marson
Rapid-Onset, Short-Duration Induction of Colorectal Contractions in Anesthetized, Adult, Male Rats. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Sneha Rathi, Ju-Hee Oh, Wenjuan Zhang, Ann C Mladek, Darwin A Garcia, Zhiyi Xue, Danielle M Burgenske, Wenqiu Zhang, Jiayan Le, Wei Zhong, Jann N Sarkaria, William F Elmquist
Preclinical Systemic Pharmacokinetics, Dose Proportionality, and Central Nervous System Distribution of the ATM Inhibitor WSD0628, a Novel Radiosensitizer for the Treatment of Brain Tumors. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Salman Ashraf, Taylor Clarkson, Anna P Malykhina
Therapeutic Approaches for Urologic Chronic Pelvic Pain Syndrome; Management: Research Advances, Experimental Targets, and Future Directions. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Dalila Andrade Pereira, Fabiano Beraldi Calmasini, Fernando Ferreira Costa, Arthur L Burnett, Fábio Henrique Silva
Nitric Oxide Resistance in Priapism Associated with Sickle Cell Disease: Mechanisms, Therapeutic Challenges, and Future Directions. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Hong Shen, Runlan Huo, Yueping Zhang, Linna Wang, Nian Tong, Weiqi Chen, Andrew J Paris, Kofi Mensah, Min Chen, Yongjun Xue, Wenying Li, Michael Sinz
A Pilot Study To Assess the Suitability of Riboflavin As a Surrogate Marker of Breast Cancer Resistance Protein in Healthy Participants. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Felix Ampadu, Vibhudutta Awasthi, Aditya D Joshi
Role of Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 Signaling in Liver and Metabolic Diseases. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Ai Sato, Sai Yasukochi, Naho Iwanaka, Tomoaki Yamauchi, Akito Tsuruta, Satoru Koyanagi, Shigehiro Ohdo
Dosing Time-Dependent Difference in the Suppressive Effect of Empagliflozin on the Development of Mechanical Pain Hypersensitivity in Diabetic Mice. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Marta Melis
Brightening the Path: Riboflavin Illuminates Breast Cancer Resistance Protein Monitoring. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Salman Ashraf, Taylor Clarkson, Anna P Malykhina
Therapeutic Approaches for Urologic Chronic Pelvic Pain Syndrome; Management: Research Advances, Experimental Targets, and Future Directions. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Jie Yin, Ye Wang, Weizhong Han, Weili Ge, Qingxia Yu, Yanyan Jing, Wenju Yan, Qian Liu, Liping Gong, Su-Hua Yan, Shuanglian Wang, Xiaolu Li, Yan Li, Hesheng Hu
Oxytocin Attenuates Sympathetic Innervation with Inhibition of Cardiac Mast Cell Degranulation in Rats after Myocardial Infarction. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Jason B Cook, Raymond Piatt, Edward Burgard, Karl B Thor, Lesley Marson
Rapid-Onset, Short-Duration Induction of Colorectal Contractions in Anesthetized, Adult, Male Rats. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Felix Ampadu, Vibhudutta Awasthi, Aditya D Joshi
Role of Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 Signaling in Liver and Metabolic Diseases. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Liya Y Qiao
Satellite Glial Cells Bridge Sensory Neuron Crosstalk in Visceral Pain and Cross-Organ Sensitization. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Ho-Poh Kek, Yu-Tsun Su, Kai-Jen Lin, Ming-Chun Yang, Li-Ching Chang, Yung-Ning Yang, Ching-Chung Tsai
Investigating the Mechanisms Underlying U46619-Induced Contraction on Porcine Lower Esophageal Sphincter. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Sneha Rathi, Ju-Hee Oh, Wenjuan Zhang, Ann C Mladek, Darwin A Garcia, Zhiyi Xue, Danielle M Burgenske, Wenqiu Zhang, Jiayan Le, Wei Zhong, Jann N Sarkaria, William F Elmquist
Preclinical Systemic Pharmacokinetics, Dose Proportionality, and Central Nervous System Distribution of the ATM Inhibitor WSD0628, a Novel Radiosensitizer for the Treatment of Brain Tumors. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Hong Shen, Runlan Huo, Yueping Zhang, Linna Wang, Nian Tong, Weiqi Chen, Andrew J Paris, Kofi Mensah, Min Chen, Yongjun Xue, Wenying Li, Michael Sinz
A Pilot Study To Assess the Suitability of Riboflavin As a Surrogate Marker of Breast Cancer Resistance Protein in Healthy Participants. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Felix Ampadu, Vibhudutta Awasthi, Aditya D Joshi
Role of Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 Signaling in Liver and Metabolic Diseases. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Liya Y Qiao
Satellite Glial Cells Bridge Sensory Neuron Crosstalk in Visceral Pain and Cross-Organ Sensitization. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Sneha Rathi, Ju-Hee Oh, Wenjuan Zhang, Ann C Mladek, Darwin A Garcia, Zhiyi Xue, Danielle M Burgenske, Wenqiu Zhang, Jiayan Le, Wei Zhong, Jann N Sarkaria, William F Elmquist
Preclinical Systemic Pharmacokinetics, Dose Proportionality, and Central Nervous System Distribution of the ATM Inhibitor WSD0628, a Novel Radiosensitizer for the Treatment of Brain Tumors. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Jason B Cook, Raymond Piatt, Edward Burgard, Karl B Thor, Lesley Marson
Rapid-Onset, Short-Duration Induction of Colorectal Contractions in Anesthetized, Adult, Male Rats. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Alex J Roy, Jeffrey R Leipprandt, Joseph R Patterson, Anna C Stoll, Christopher J Kemp, Zaipo-Tcheisian D Oula, Tyler Mola, Ana R Batista, Caryl E Sortwell, Miguel Sena-Esteves, Richard R Neubig
AAV9-Mediated Intrastriatal Delivery of GNAO1 Reduces Hyperlocomotion in Gnao1 Heterozygous R209H Mutant Mice. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Andrea Cignarella, Cristina D Peterson
Mechanistic Chronopharmacology: Preclinical Modeling of an SGLT2 Inhibitor in Preventing Painful Diabetic Neuropathy. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Felix Ampadu, Vibhudutta Awasthi, Aditya D Joshi
Role of Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 Signaling in Liver and Metabolic Diseases. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Sneha Rathi, Ju-Hee Oh, Wenjuan Zhang, Ann C Mladek, Darwin A Garcia, Zhiyi Xue, Danielle M Burgenske, Wenqiu Zhang, Jiayan Le, Wei Zhong, Jann N Sarkaria, William F Elmquist
Preclinical Systemic Pharmacokinetics, Dose Proportionality, and Central Nervous System Distribution of the ATM Inhibitor WSD0628, a Novel Radiosensitizer for the Treatment of Brain Tumors. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Liya Y Qiao
Satellite Glial Cells Bridge Sensory Neuron Crosstalk in Visceral Pain and Cross-Organ Sensitization. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Salman Ashraf, Taylor Clarkson, Anna P Malykhina
Therapeutic Approaches for Urologic Chronic Pelvic Pain Syndrome; Management: Research Advances, Experimental Targets, and Future Directions. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Salman Ashraf, Taylor Clarkson, Anna P Malykhina
Therapeutic Approaches for Urologic Chronic Pelvic Pain Syndrome; Management: Research Advances, Experimental Targets, and Future Directions. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)
Jason B Cook, Raymond Piatt, Edward Burgard, Karl B Thor, Lesley Marson
Rapid-Onset, Short-Duration Induction of Colorectal Contractions in Anesthetized, Adult, Male Rats. The Journal of pharmacology and experimental therapeutics 390 (2) (2024)

volume 390, number 3, 2024

Clare M Diester, Hallie Balint, James C Gillespie, Aron H Lichtman, Laura J Sim-Selley, Dana E Selley, S Stevens Negus
Effects of Repeated Treatment with the Monoacylglycerol Lipase Inhibitor MJN110 on Pain-Related Depression of Nesting and Cannabinoid 1 Receptor Function in Male and Female Mice. The Journal of pharmacology and experimental therapeutics 390 (3) (2024)
Karl B Thor, Lesley Marson, Mary A Katofiasc, Daniel J Ricca, Edward C Burgard
Recent Developments in On-Demand Voiding Therapies. The Journal of pharmacology and experimental therapeutics 390 (3) (2024)
Benjamin D Anderson, Diana E Sepulveda, Rahul Nachnani, Alonso Cortez-Resendiz, Matthew D Coates, Aviauna Beckett, Jordan E Bisanz, Joshua J Kellogg, Wesley M Raup-Konsavage
High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model. The Journal of pharmacology and experimental therapeutics 390 (3) (2024)
Clare M Diester, Hallie Balint, James C Gillespie, Aron H Lichtman, Laura J Sim-Selley, Dana E Selley, S Stevens Negus
Effects of Repeated Treatment with the Monoacylglycerol Lipase Inhibitor MJN110 on Pain-Related Depression of Nesting and Cannabinoid 1 Receptor Function in Male and Female Mice. The Journal of pharmacology and experimental therapeutics 390 (3) (2024)
Benjamin D Anderson, Diana E Sepulveda, Rahul Nachnani, Alonso Cortez-Resendiz, Matthew D Coates, Aviauna Beckett, Jordan E Bisanz, Joshua J Kellogg, Wesley M Raup-Konsavage
High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model. The Journal of pharmacology and experimental therapeutics 390 (3) (2024)
Benjamin D Anderson, Diana E Sepulveda, Rahul Nachnani, Alonso Cortez-Resendiz, Matthew D Coates, Aviauna Beckett, Jordan E Bisanz, Joshua J Kellogg, Wesley M Raup-Konsavage
High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model. The Journal of pharmacology and experimental therapeutics 390 (3) (2024)
Masashi Tawa, Keisuke Nakagawa, Mamoru Ohkita
Efficacy of BAY 60-2770, a Soluble Guanylate Cyclase Activator, for Coronary Spasm in Animal Models. The Journal of pharmacology and experimental therapeutics 390 (3) (2024)
Karl B Thor, Lesley Marson, Mary A Katofiasc, Daniel J Ricca, Edward C Burgard
Recent Developments in On-Demand Voiding Therapies. The Journal of pharmacology and experimental therapeutics 390 (3) (2024)
Clare M Diester, Hallie Balint, James C Gillespie, Aron H Lichtman, Laura J Sim-Selley, Dana E Selley, S Stevens Negus
Effects of Repeated Treatment with the Monoacylglycerol Lipase Inhibitor MJN110 on Pain-Related Depression of Nesting and Cannabinoid 1 Receptor Function in Male and Female Mice. The Journal of pharmacology and experimental therapeutics 390 (3) (2024)
Clare M Diester, Hallie Balint, James C Gillespie, Aron H Lichtman, Laura J Sim-Selley, Dana E Selley, S Stevens Negus
Effects of Repeated Treatment with the Monoacylglycerol Lipase Inhibitor MJN110 on Pain-Related Depression of Nesting and Cannabinoid 1 Receptor Function in Male and Female Mice. The Journal of pharmacology and experimental therapeutics 390 (3) (2024)
Shinji Kobuchi, Mayuka Arimoto, Yukako Ito
Translational Pharmacokinetic-Toxicodynamic Model of Myelosuppression for Dose Optimization in Combination Chemotherapy of Capecitabine and Oxaliplatin from Rats to Humans. The Journal of pharmacology and experimental therapeutics 390 (3) (2024)
John F Beltrame, David P Wilson
Developing Novel Therapies in Coronary Vasomotor Disorders: Translational Gaps from Basic Science to Clinical Impact. The Journal of pharmacology and experimental therapeutics 390 (3) (2024)
Karl B Thor, Lesley Marson, Mary A Katofiasc, Daniel J Ricca, Edward C Burgard
Recent Developments in On-Demand Voiding Therapies. The Journal of pharmacology and experimental therapeutics 390 (3) (2024)
Jenny L Wilkerson
Seeing through the Haze: Monoacylglycerol Lipase Inhibitors As Analgesics. The Journal of pharmacology and experimental therapeutics 390 (3) (2024)
Benjamin D Anderson, Diana E Sepulveda, Rahul Nachnani, Alonso Cortez-Resendiz, Matthew D Coates, Aviauna Beckett, Jordan E Bisanz, Joshua J Kellogg, Wesley M Raup-Konsavage
High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model. The Journal of pharmacology and experimental therapeutics 390 (3) (2024)
Karl B Thor, Lesley Marson, Mary A Katofiasc, Daniel J Ricca, Edward C Burgard
Recent Developments in On-Demand Voiding Therapies. The Journal of pharmacology and experimental therapeutics 390 (3) (2024)